Hemoglobin A1C HbA1C

Added to your cart

Hemoglobin A1C HbA1C

Cart subtotal: £0.00

View cart (0) Checkout

#SKU P186-0B

£35.68

Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

Glycosylated hemoglobin A1c (HbA1c) levels are used as an indicator of blood glucose in diabetic patients. It is formed by the conjugation of a hexose sugar to the beta-chain of hemoglobin A. HbA1c builds up in red blood cells throughout their lifetime and its levels therefore represent a record of blood glucose levels over the previous 8 weeks or so. The hemoglobin A1c subunit has a molecular weight of 18kDa.

0.1mg
P186-0B

More information

Attributes

Description

  • Shipping Information
  • Dry Ice
  • Abbreviations
  • HbA1C
  • Specification
  • >96% HbA1c
  • Recommended Use
  • Research and further manufacturing
  • Preservatives
  • proprietary buffer formulation
  • Buffer
  • proprietary buffer formulation, pH 8.0.
  • Presentation Matrix
  • proprietary buffer formulation, pH 8.0.
  • Purity/grade
  • >96%
  • Source
  • human erythrocytes
  • Molecular weight
  • 64kDa
  • Uniprot No.
  • P69905/Q6VFQ6

Technical Documents

Certificates Of Analysis (77.61KB)

Safety Data Sheet (38.84KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox